Medscape © 2022 WebMD, LLC Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape. Cite this: Ovarian Cancer Clinical Practice Guidelines (NCCN, 2022) - Medscape - Sep 29, 2022....
Ovarian cancer is any cancer that affects the ovaries. It occurs mostly in post-menopausal women, but can occur at any age.1 About 1.1% of women will be diagnosed with ovarian cancer in their lifetime.2 It is the fifth-most-common cause of cancer death in women.3 Women with ovarian ...
NewsNCCN, AstraZeneca Projects Target Advanced Ovarian Cancer Patients NewsCediranib-Lynparza Combo Fails to Delay Disease Progression in Relapsed Ovarian Cancer NewsCytoDyn Cleared to Start Phase 2 Basket Trial of Leronlimab for Multiple Solid Cancers ...
NCCN Updates Ovarian Cancer GuidelinesAnis unavailable. This article is available as HTML full text and PDF.doi:10.1097/01.COT.0000397191.46574.8bSusmanEdOncology Times
Ovarian cancer is a formidable disease characterized by the abnormal growth of cells in the ovaries, often presenting with subtle or nonspecific symptoms in its early stages, leading to challenges in early detection. As one of the deadliest gynecological malignancies, ovarian cancer is typically diagno...
In order to evaluate the risk of cardiovascular mortality in patients with ovarian cancer, we included influencing factors including age, histological type, surgical method, chemotherapy, whether distant metastasis, race and developed a nomogram to evaluate the ability to predict occurrence. At present,...
Surgery for platinum-sensitive, relapsed ovarian cancer (PSROC) is widely practiced but had contradictory survival outcomes in previous studies. In this multicenter, open-label, phase 3 trial, women with PSROC, and having had one previous therapy and no platinum-based chemotherapy (platinum-free...
Consistent with recommendations from authoritative bodies such as the National Comprehensive Cancer Network (NCCN) and the American College of Obstetricians and Gynecologists (ACOG), referral to a gynecologic oncologist for further evaluation and treatment is advised for all patients with suspected ovarian ...
This selection from the NCCN Guidelines for Ovarian Cancer focuses on the less common ovarian histopathologies (LCOHs), because new algorithms were added for LCOHs and current algorithms were revised for the 2016 update. The new LCOHs algorithms include clear cell carcinomas, mucinous carcinomas,...
Epithelial ovarian cancer (EOC) is a deadly disease with limited diagnostic biomarkers and therapeutic targets. Here we conduct a comprehensive proteomic profiling of ovarian tissue and plasma samples from 813 patients with different histotypes and thera